Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-018104
Filing Date
2012-03-29
Accepted
2012-03-29 16:43:46
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v307149_10k.htm 10-K 886125
2 EXHIBIT31.1 v307149_ex31-1.htm EX-31.1 9482
3 EXHIBIT31.2 v307149_ex31-2.htm EX-31.2 9507
4 EXHIBIT32.1 v307149_ex32-1.htm EX-32.1 4123
5 GRAPHIC logo.jpg GRAPHIC 33045
  Complete submission text file 0001144204-12-018104.txt   3171856

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptbg-20111231.xml EX-101.INS 451466
7 XBRL TAXONOMY EXTENSION SCHEMA ptbg-20111231.xsd EX-101.SCH 25457
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptbg-20111231_cal.xml EX-101.CAL 32569
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptbg-20111231_def.xml EX-101.DEF 80231
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptbg-20111231_lab.xml EX-101.LAB 177746
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptbg-20111231_pre.xml EX-101.PRE 106371
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51474 | Film No.: 12724523
SIC: 2834 Pharmaceutical Preparations